Cargando…

Gout in primary care: Can we improve patient outcomes?

In the United Kingdom, gout represents one of the most common inflammatory arthropathies predominantly managed in the primary care setting. Gout is a red flag indicator for cardiovascular disease and comorbidity. Despite this, there are no incentivised treatment protocols and suboptimal management i...

Descripción completa

Detalles Bibliográficos
Autores principales: Callear, Jacqueline, Blakey, Georgina, Callear, Alexandra, Sloan, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411725/
https://www.ncbi.nlm.nih.gov/pubmed/28469909
http://dx.doi.org/10.1136/bmjquality.u210130.w4918
_version_ 1783232855706435584
author Callear, Jacqueline
Blakey, Georgina
Callear, Alexandra
Sloan, Linda
author_facet Callear, Jacqueline
Blakey, Georgina
Callear, Alexandra
Sloan, Linda
author_sort Callear, Jacqueline
collection PubMed
description In the United Kingdom, gout represents one of the most common inflammatory arthropathies predominantly managed in the primary care setting. Gout is a red flag indicator for cardiovascular disease and comorbidity. Despite this, there are no incentivised treatment protocols and suboptimal management in the primary care setting is common. A computer based retrospective search at a large inner city GP practice between January 2014-December 2014 inclusive, identified 115 patients with gout. Baseline measurements revealed multiple gout related consultations, poor medication compliance, high uric acid levels and deficiencies in uric acid monitoring. A series of improvement cycles were conducted. A telephone questionnaire conducted in January 2015, identified that patient education was suboptimal. The following improvement cycles aimed to educate patients, improve uric acid monitoring and support medication compliance. It was ultimately hoped that these measures would reduce gout flares and GP practice attendance. The improvement cycles contributed towards reduction in uric acid levels from 0.37 to 0.3 (p=0.14), 20% reduction in patients experiencing one or more gout flares and 77% reduction in GP related consultations between March 2015-March 2016 compared to baseline. The proportion of patients fully compliant with taking their urate lowering therapies improved from 63% to 91% (p=0.0001). A follow up series of PDSA cycles were performed between July-December 2016. The purpose of these cycles was to assess the sustainability of the improved medication compliance demonstrated by the improvement cycles. Three months following the completion of the improvement cycles, full medication compliance dropped from 91% to 70% (p=0.0001). The introduction of a paper calendar saw sustained and maintained improvement in medication compliance to 100% (p=0.0001) at the end of the study period. The improvement and PDSA cycles have demonstrated that simple interventions can be a sustainable way of improving disease control and patient outcomes.
format Online
Article
Text
id pubmed-5411725
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher British Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54117252017-05-03 Gout in primary care: Can we improve patient outcomes? Callear, Jacqueline Blakey, Georgina Callear, Alexandra Sloan, Linda BMJ Qual Improv Rep BMJ Quality Improvement Programme In the United Kingdom, gout represents one of the most common inflammatory arthropathies predominantly managed in the primary care setting. Gout is a red flag indicator for cardiovascular disease and comorbidity. Despite this, there are no incentivised treatment protocols and suboptimal management in the primary care setting is common. A computer based retrospective search at a large inner city GP practice between January 2014-December 2014 inclusive, identified 115 patients with gout. Baseline measurements revealed multiple gout related consultations, poor medication compliance, high uric acid levels and deficiencies in uric acid monitoring. A series of improvement cycles were conducted. A telephone questionnaire conducted in January 2015, identified that patient education was suboptimal. The following improvement cycles aimed to educate patients, improve uric acid monitoring and support medication compliance. It was ultimately hoped that these measures would reduce gout flares and GP practice attendance. The improvement cycles contributed towards reduction in uric acid levels from 0.37 to 0.3 (p=0.14), 20% reduction in patients experiencing one or more gout flares and 77% reduction in GP related consultations between March 2015-March 2016 compared to baseline. The proportion of patients fully compliant with taking their urate lowering therapies improved from 63% to 91% (p=0.0001). A follow up series of PDSA cycles were performed between July-December 2016. The purpose of these cycles was to assess the sustainability of the improved medication compliance demonstrated by the improvement cycles. Three months following the completion of the improvement cycles, full medication compliance dropped from 91% to 70% (p=0.0001). The introduction of a paper calendar saw sustained and maintained improvement in medication compliance to 100% (p=0.0001) at the end of the study period. The improvement and PDSA cycles have demonstrated that simple interventions can be a sustainable way of improving disease control and patient outcomes. British Publishing Group 2017-04-25 /pmc/articles/PMC5411725/ /pubmed/28469909 http://dx.doi.org/10.1136/bmjquality.u210130.w4918 Text en © 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/http://creativecommons.org/licenses/by-nc/2.0/legalcode
spellingShingle BMJ Quality Improvement Programme
Callear, Jacqueline
Blakey, Georgina
Callear, Alexandra
Sloan, Linda
Gout in primary care: Can we improve patient outcomes?
title Gout in primary care: Can we improve patient outcomes?
title_full Gout in primary care: Can we improve patient outcomes?
title_fullStr Gout in primary care: Can we improve patient outcomes?
title_full_unstemmed Gout in primary care: Can we improve patient outcomes?
title_short Gout in primary care: Can we improve patient outcomes?
title_sort gout in primary care: can we improve patient outcomes?
topic BMJ Quality Improvement Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411725/
https://www.ncbi.nlm.nih.gov/pubmed/28469909
http://dx.doi.org/10.1136/bmjquality.u210130.w4918
work_keys_str_mv AT callearjacqueline goutinprimarycarecanweimprovepatientoutcomes
AT blakeygeorgina goutinprimarycarecanweimprovepatientoutcomes
AT callearalexandra goutinprimarycarecanweimprovepatientoutcomes
AT sloanlinda goutinprimarycarecanweimprovepatientoutcomes